Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245911 | SCV000302079 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000710825 | SCV000718877 | benign | not provided | 2019-06-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710825 | SCV000841130 | benign | not provided | 2018-08-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710825 | SCV001109088 | benign | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001139015 | SCV001299121 | benign | Alport syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Ce |
RCV000710825 | SCV002496642 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | COL4A3: BP4, BP7 |
ARUP Laboratories, |
RCV000710825 | SCV004564882 | likely benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000710825 | SCV005259039 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000710825 | SCV001955528 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000710825 | SCV001970021 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001139015 | SCV002076439 | likely benign | Alport syndrome | 2021-02-24 | no assertion criteria provided | clinical testing |